BioCentury
ARTICLE | Clinical News

AtheNA Multi-Lyte ANA Test System regulatory update

December 24, 2001 8:00 AM UTC

The FDA granted 510(k) marketing clearance for Zeus's AtheNA Multi-Lyte ANA test system to detect autoimmune diseases. The system, which is based on LMNX's LabMAP bioassay technology, detects nine sep...